Navigation Links
Genta Receives Key Patent Related to Oral Gallium Compound G4544
Date:4/14/2008

. Ganite is exclusively marketed in the U.S. by Genta and is available to patients outside the U.S. on a "named-patient" basis.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genta is currently recruiting patients to the AGENDA Trial, a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, that has recently entered clinical trials as a potential treatment for diseases associated with accelerated bone loss. The Company is also developing tesetaxel, a novel, orally absorbed, semi- synthetic taxane that is in the same class of drugs as paclitaxel and docetaxel. Ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our website at: http://www.genta.com.

Safe Harbor

This press release may contain forward-looking statements with respect to business conducted by Genta Incorporated. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Forward- looking statements include, without limitation, statements about:

-- the Company's ability to obtain necessary regulatory app
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
3. Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
4. Genta Incorporated Announces Third Quarter 2007 Financial Results
5. Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases
6. Genta Clinical Programs Featured at American Society of Hematology Meeting
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
10. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
11. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... -- Reportbuyer.com has added a new market research report: ... https://www.reportbuyer.com/product/98394/Global-Cardiac-Defibrillators-Industry.html This report analyzes the worldwide ... following Product Segments: Implantable/Internal Cardiac Defibrillators, and External Defibrillators. ... Canada , Japan ... , Middle East & ...
(Date:8/20/2014)... The National Necrotizing Fasciitis Foundation (NNFF) today announced ... successfully treated for a life threatening form of necrotizing fasciitis, ... , Medical Director of Inpatient Wound Care and founder of ... Rancho Mirage, California . Dr. ... Crew at Seton Hospital in Daly City, ...
(Date:8/20/2014)... NEW YORK , Aug. 20, 2014 ... market research report is available in its ... (The Market for Bluetooth, RFID, Zigbee, UWB ... http://www.reportlinker.com/p0652514/Wireless-Opportunities-in-Healthcare-The-Market-for-Bluetooth-RFID-Zigbee-UWB-WWAN-WMAN-WLAN-and-other-technologies.html ... Market for Bluetooth, RFID, Zigbee, UWB WWAN, ...
Breaking Medicine Technology:Global Cardiac Defibrillators Industry 2Global Cardiac Defibrillators Industry 3Global Cardiac Defibrillators Industry 4Global Cardiac Defibrillators Industry 5Global Cardiac Defibrillators Industry 6Global Cardiac Defibrillators Industry 7Global Cardiac Defibrillators Industry 8Global Cardiac Defibrillators Industry 9Global Cardiac Defibrillators Industry 10Global Cardiac Defibrillators Industry 11Global Cardiac Defibrillators Industry 12Global Cardiac Defibrillators Industry 13Global Cardiac Defibrillators Industry 14Global Cardiac Defibrillators Industry 15Global Cardiac Defibrillators Industry 16Global Cardiac Defibrillators Industry 17Global Cardiac Defibrillators Industry 18Global Cardiac Defibrillators Industry 19Global Cardiac Defibrillators Industry 20Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 3Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 4Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 5Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 6Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 2Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 3Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 4Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 5Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 6Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 7Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 8Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 9Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 10Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 11Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 12
... (NASDAQ: ANGN ) today scheduled a conference call to ... 2011, ended July 31, 2011. The call will be at 4:30 ... financial results for the third quarter of fiscal year 2011 after ... Those wishing to participate can dial (877) 317-6789 or (412) 317-6789 ...
... Virginia, August 25, 2011 Ekahau ... Real Time Location Systems (RTLS), today ... integrated into a healthcare telecommunications system developed by ... provide location tracking capabilities to HEALTHCAREwireless™, which is ...
Cached Medicine Technology:Angeion Corporation to Report Third Quarter Fiscal Year 2011 Financial Results on Thursday, September 1, 2011 2Ekahau Joins Forces with LPS Services to Deliver Location Tracking for HEALTHCAREwireless™ Solution 2Ekahau Joins Forces with LPS Services to Deliver Location Tracking for HEALTHCAREwireless™ Solution 3
(Date:8/20/2014)... York, NY (PRWEB) August 20, 2014 Ticket ... Tennis Championship tickets in NYC. In just a week, ... Billie Jean King Tennis Center. The event was originally founded in ... 2013 event, Rafael Nadal was forced to withdrawal from the event ... the 2014 women’s tournament and will return to New York City ...
(Date:8/20/2014)... A study in Australia examined patient and tumor ... marker of tumor cell growth) in an effort ... in patients. , Author: Sarah ... Australia, and colleagues. , Background: The tumor ... division) has been connected with prognosis and survival ...
(Date:8/20/2014)... to deploy Ebola vaccines is now, Free content, ... according to a commentary being published early online today ... The authors from Yale School of Public Health write ... the current Ebola outbreak represent a public health crisis ... Several Ebola vaccines have been developed in the last ...
(Date:8/20/2014)... WEDNESDAY, Aug. 20, 2014 (HealthDay News) -- Loss of ... help explain why many seniors have trouble falling and ... patients, sleep disruption can be especially severe and often ... researchers. The investigators analyzed data from the Rush ... who enrolled at age 65 and are being followed ...
(Date:8/20/2014)... 20, 2014 The Board of Directors ... Eastman is pleased to announce the expansion of ... China and the surrounding region. In support ... Sprow AIA has relocated to the firm’s office ... healthcare planning and design and to better support regional ...
Breaking Medicine News(10 mins):Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Patient, tumor characteristics for high-mitotic rate melanoma 2Health News:News from Annals of Internal Medicine 2Health News:Seniors' Sleep Woes May Be Linked to Loss of Brain Cells 2Health News:Perkins Eastman Expands Presence in China 2Health News:Perkins Eastman Expands Presence in China 3
... division of inVentiv Health, Inc. (Nasdaq: VTIV ) was ... 125 top training companies.,This is the fourth year in a ... second year it has been in the top 20., ... been,measured on qualitative and quantitative data. An outside research and,statistical ...
... WELLINGTON, Fla., Feb. 14 The Quantum Group,Inc. (Amex: ... has reported fourth quarter and year end financial results ... Company reported a 4,700% increase in total revenues recorded ... year 2007. Further, the,Company reported a 5,044% increase in ...
... Percent Increase Would Raise Average Benefit Just $30.20 ... Late last month, the,Congressional Budget Office published ... a 2.8 percent increase in their Social,Security checks ... at least five million people aged 65 and ...
... ... OAKLAND, Calif., Feb. 14 Kaiser Foundation Health Plan,Inc., Kaiser ... the fourth quarter ended December 31,2007 of $9.6 billion which compares ... loss of $233 million for the quarter versus net income,of $215 ...
... Management Assists Decision Makers in, Designing ... PHILADELPHIA, Feb. 14 GlaxoSmithKline (GSK),today ... Value-Based Health Management, (http://www.CenterVBHM.com ), an online ... the health of their workforce while lowering,overall ...
... New research finds that both men and women place a ... With Valentine,s Day as a backdrop, researchers are taking a ... turning some long-held assumptions on their pretty heads. , Debunked ... while women prioritize mates by the size of their wallets. ...
Cached Medicine News:Health News:inVentiv Health Ranked #17 by Training Magazine in its 2008 List of Top 125 Training Companies 2Health News:inVentiv Health Ranked #17 by Training Magazine in its 2008 List of Top 125 Training Companies 3Health News:The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007 2Health News:The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007 3Health News:Newly Released 2009 COLA Forecast Would Keep Five Million Seniors Below Poverty Line 2Health News:Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year-End 2007 Financial Results 2Health News:Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year-End 2007 Financial Results 3Health News:Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year-End 2007 Financial Results 4Health News:GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 2Health News:GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 3Health News:GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 4Health News:When It Comes to a Mate, Beauty Can't Be Beat 2Health News:When It Comes to a Mate, Beauty Can't Be Beat 3
... Reliability, quality and convenience make ... workhorse for the small workload laboratory. ... with a capacity of 26 tests ... a throughput up 200 tests per ...
The Advia IMS integrates a full menu of both immunoassay and chemistry tests....
... Diagnostics Task Targeted Automation VS II ... pre- and post-analytical steps in the ... primary tubes and aliquoting into bar ... and extendable to future needs. Works ...
... Task Targeted Automation PSD 1 ... of pre- and post-analytical steps ... / archiving of primary tubes ... labeled secondary tubes. Fully scalable ...
Medicine Products: